How can digital and AI optimise the delivery of patient support programs in cancer?

How can digital and AI optimise the delivery of patient support programs in cancer?

Oncology patient support programs (PSPs) hold great promise for cancer patients, clinicians, and drug makers by providing patients with literature and resources that help them cope with their disease and treatment experiences. However, these PSPs often fall short of delivering the dynamic, responsive, and personalised experience that patients have come to expect in other areas of their lives – be it banking, entertainment, travelling, or even news. This raises questions about the suitability and sustainability of legacy approaches to implementing oncology PSPs in an increasingly digitised healthcare system against a backdrop of evolving patient expectations.

With the recent emergence of digital and AI-native platforms like Vinehealth, the opportunity exists for oncology PSPs to embrace innovative approaches that meet the interests and needs of the individual cancer patient, but at the scale of an NHS Trust, networks of cancer facilities, or even national populations across tumour types and care pathways. Join us to learn about the pivotal role oncology PSPs can continue to play in cancer care, and the opportunities and challenges AI-powered digital cancer support platforms present to clinicians and drug makers. How close is the vision and promise to reality, and how can you tap into these next-generation digital oncology platforms to create and deliver value for your patients and your organisation? Join us to discuss the opportunities and challenges of deploying a digital cancer support platform in clinical practice and discover how close is the Pharma vision to reality.

About the panel

Jack Harris, VP Oncology UK, GSK
Jack Harris is Vice President, Head of Oncology for GSK in the UK, responsible for GSK’s Oncology portfolio in the UK, with a particular passion for accelerating access, uptake and impact of oncology medicines. Jack joined GSK in November 2021 and has worked in the pharmaceutical industry for almost 20 years in various marketing, sales and market access roles, both in the UK and across Europe, the Middle East & Africa and has worked in the Oncology therapy area for over 8 years.

Giles Davies, Consultant oncoplastic breast surgeon, Director of breast surgery Cromwell Hospital
Mr Davies trained at St George's Hospital Medical School and was an NHS Consultant for 10 years at Kingston Hospital and the Royal Marsden Hospital where he maintains an honorary contract. Mr Davies has specialist expertise in all areas of breast cancer surgery from assessment and breast cancer surgery through to complex breast reconstruction. His research programme in human papillomavirus and breast cancer is based in the UK and in Doha, Qatar.

Rayna Patel, Co-Founder and CEO, Vinehealth
Dr Rayna Patel is a medical doctor & neuroscientist (Cambridge, Harvard, MIT, Columbia). She graduated top of her year from Medicine at Cambridge, and later returned there to complete a GSK-funded MPhil in Translational Medicine (i.e. translating drugs from clinical trials to patients), in which she received a distinction. She has extensive experience in academic and clinical trial research. Rayna has held strategic & commercial roles in government policy, tech startups & the Cabinet Office’s Nudge Unit, leading the way in using behavioural science to rewire patient behaviours through commercial products, before co-founding Vine Health.

Eloise McLennan, Deep Dive editor (moderator)
Eloise McLennan is the editor for pharmaphorum’s Deep Dive magazine. She has been a journalist and editor in the healthcare field for more than five years and has worked at several leading publications in the UK.